Award

SARS-COV-2 VACCINE SUPPLY AGREEMENT

BUSINESS ENERGY AND INDUSTRIAL STRATEGY

This public procurement record has 1 release in its history.

Award

12 Feb 2021 at 17:15

Award Notice
Summary of the contracting process

The procurement process involves the Business Energy and Industrial Strategy as the buying organisation, which has completed a tender for a SARS-CoV-2 Vaccine Supply Agreement. This procurement falls under the goods category, specifically for vaccines, and is located in the United Kingdom. The contract, worth £1, was awarded to Novavax Inc. on 22nd October 2020, following a single tender action method, and the contract period extends until 31st December 2021.

This tender presents an opportunity for businesses in the pharmaceutical and healthcare sectors, particularly those involved in vaccine production and distribution. Companies with established capabilities in vaccine development, manufacturing, or related supply chain logistics would be well-suited to compete in future procurement processes of this nature, given the ongoing demand for innovative vaccine solutions.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

SARS-COV-2 VACCINE SUPPLY AGREEMENT

Notice Description

Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/440445d9-888f-4b09-8fdf-465f913b7ca0
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Single tender action (below threshold)
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
£1
Contracts Value
Not specified

Notice Dates

Publication Date
12 Feb 20215 years ago
Submission Deadline
21 Oct 2020Expired
Future Notice Date
Not specified
Award Date
21 Oct 20205 years ago
Contract Period
21 Oct 2020 - 31 Dec 2021 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
BUSINESS ENERGY AND INDUSTRIAL STRATEGY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW1H 0ET
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
St James's
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
1
Supplier Name

NOVAVAX

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633-2021-02-12T17:15:00Z",
    "date": "2021-02-12T17:15:00Z",
    "ocid": "ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "4681/10/2020",
        "title": "SARS-COV-2 VACCINE SUPPLY AGREEMENT",
        "description": "Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans. Note: This notice corrects and supersedes a previous notice (see links section). It does not represent a new arrangement or contract with the supplier. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33651600",
            "description": "Vaccines"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 1,
            "currency": "GBP"
        },
        "procurementMethod": "direct",
        "procurementMethodDetails": "Single tender action (below threshold)",
        "tenderPeriod": {
            "endDate": "2020-10-21T23:59:00+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-10-22T00:00:00+01:00",
            "endDate": "2021-12-31T23:59:59Z"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
            "name": "Business Energy and Industrial Strategy",
            "identifier": {
                "legalName": "Business Energy and Industrial Strategy",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/57hG7nME"
            },
            "address": {
                "streetAddress": "1 Victoria Street",
                "locality": "London",
                "postalCode": "SW1H0ET",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "VTFContracts@beis.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-161665",
            "name": "Novavax Inc.",
            "identifier": {
                "legalName": "Novavax Inc."
            },
            "address": {
                "streetAddress": "21 Firstfield Road Gaithersburg 20878"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
        "name": "Business Energy and Industrial Strategy"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-67b7cef9-d0b0-4c48-be40-dc16b02b0633-1",
            "status": "active",
            "date": "2020-10-22T00:00:00+01:00",
            "datePublished": "2021-02-12T17:15:00Z",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-161665",
                    "name": "Novavax Inc."
                }
            ],
            "contractPeriod": {
                "startDate": "2020-10-22T00:00:00+01:00",
                "endDate": "2021-12-31T23:59:59Z"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/440445d9-888f-4b09-8fdf-465f913b7ca0",
                    "datePublished": "2021-02-12T17:15:00Z",
                    "format": "text/html",
                    "language": "en"
                },
                {
                    "id": "2",
                    "documentType": "contractNotice",
                    "description": "This link refers to the original notice that is corrected and superseded by this notice.",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/c1ed715e-9a39-4263-961f-dc8166a81216"
                },
                {
                    "id": "3",
                    "documentType": "contractSigned",
                    "description": "SARS-COV2 VACCINE SUPPLY AGREEMENT - [REDACTED]",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/SupplierAttachment/5b800abd-2b73-4bcd-be80-29567791f87e",
                    "format": "application/pdf"
                }
            ]
        }
    ]
}